GRAIL, Inc. (Nasdaq: GRAL), a healthcare company focused on early cancer detection, has announced the issuance of equity awards to 38 newly hired non-executive employees. These awards, in the form of restricted stock units (RSUs) totaling 77,350 shares of GRAIL's common stock, serve as inducements for their acceptance of employment. The awards were granted under GRAIL's Inducement Equity Incentive Plan in alignment with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over approximately four years, with 25% vesting on May 31, 2026, and subsequent vesting on each anniversary of this date, contingent on continued employment with the company.
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。